Case Study: AngioDynamics raises awareness of prostate cancer focal therapy with SCS Marketing & PR

AngioDynamics secures national coverage in The Times, Daily Telegraph and Daily Mail with SCS Marketing & PR

AngioDynamics, a U.S. medical technology company, faced the challenge of raising awareness for its NanoKnife System, a focal therapy for prostate cancer, and the wider issue of inconsistent patient access to newer treatments that offer better quality-of-life outcomes. SCS Marketing & PR was engaged to develop a public relations campaign to address this.

SCS Marketing & PR crafted a PR strategy that framed the issue around patient outcomes and access to innovative treatment. The solution generated high-profile national media coverage in major UK publications, successfully positioning NanoKnife as a credible option and bringing the conversation about focal therapy and patient choice into the national spotlight.

AngioDynamics